A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis - Superficial Thrombophlebitis Treated By Enoxaparin Study Group. (Arch Intern Med, 2003)